Eisai
Senior scientific role within Eisai’s oncology development organization focused on advancing imaging science to support clinical and translational goals. The position centers on integrating imaging and biomarker approaches across the company’s oncology portfolio and elevating Eisai’s scientific presence in the field. This is a remote role contributing to the company’s mission in neurology and oncology research.
Headquarters
Nutley, New Jersey, United States
Company Size
1001-5000 employees
Founded
1995
Welcome to the Eisai Official Corporate Website Eisai Co., Ltd. Page.
We’re teaming up with Eisai to help fight cancer
5 hours ago
Eisai chooses 'Pokémon Sleep' app to battle bad sleep habits in awareness campaign
10 hours ago
Eisai to Present the Latest Data on Long-Term, Real-World Treatment with Lecanemab at the AD/PD™ 2026 Annual Meeting
2 days ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Eisai.
Eisai Launches Awareness Campaign on Importance of Sleep Through "Pokemon Sleep" Collaboration
18 hours ago
Sr Principal Scientist - Imaging
Regeneron Pharmaceuticals
Clinical Imaging Scientific Director (Oncology)
Regeneron Pharmaceuticals
Translation Imaging Lead m/f/d
City of Duncan, Oklahoma
Clinical Imaging Specialist
Integrated Resources INC
Director, Imaging Biomarkers
Dyne Therapeutics
Oncology Imaging Scientific Lead
Regeneron Pharmaceuticals